CL2016002890A1 - Peptides with antimicrobial activity - Google Patents

Peptides with antimicrobial activity

Info

Publication number
CL2016002890A1
CL2016002890A1 CL2016002890A CL2016002890A CL2016002890A1 CL 2016002890 A1 CL2016002890 A1 CL 2016002890A1 CL 2016002890 A CL2016002890 A CL 2016002890A CL 2016002890 A CL2016002890 A CL 2016002890A CL 2016002890 A1 CL2016002890 A1 CL 2016002890A1
Authority
CL
Chile
Prior art keywords
treatment
peptides
bacteria
antimicrobial activity
antibiotics
Prior art date
Application number
CL2016002890A
Other languages
Spanish (es)
Inventor
Rojas Jorge Araya
Franco Hernán Sagua
Gallardo Marco Ramirez
Cortes Jorge Gonzalez
Rodriguez Alejandro Catalan
Cortes Iván Neira
Lillo Patricio Orrego
Gonzalez Kely Ordenes
Castro Daniel Mieres
Araya William Cortes
Alonso Camilo Urbina
Original Assignee
Univ Antofagasta
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Antofagasta filed Critical Univ Antofagasta
Priority to CL2016002890A priority Critical patent/CL2016002890A1/en
Publication of CL2016002890A1 publication Critical patent/CL2016002890A1/en
Priority to PCT/CL2017/050063 priority patent/WO2018085954A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/56—Materials from animals other than mammals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/02—Peptides of undefined number of amino acids; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Communicable Diseases (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

<p>La invención aquí descrita tiene su principal campo de aplicación en el desarrollo de productos para inhibir y destruir bacterias, con especial aplicabilidad al tratamiento de enfermedades infectocontagiosas causadas por bacterias, en particular en el tratamiento de aquellas bacterias que no responden al tratamiento con antibióticos o que han desarrollado resistencia a los antibióticos existentes</p><p> The invention described herein has its main field of application in the development of products for inhibiting and destroying bacteria, with special applicability to the treatment of infectious and contagious diseases caused by bacteria, in particular in the treatment of those bacteria that do not respond to treatment with antibiotics or have developed resistance to existing antibiotics </p>

CL2016002890A 2016-11-14 2016-11-14 Peptides with antimicrobial activity CL2016002890A1 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
CL2016002890A CL2016002890A1 (en) 2016-11-14 2016-11-14 Peptides with antimicrobial activity
PCT/CL2017/050063 WO2018085954A1 (en) 2016-11-14 2017-11-14 Antimicrobial peptides

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CL2016002890A CL2016002890A1 (en) 2016-11-14 2016-11-14 Peptides with antimicrobial activity

Publications (1)

Publication Number Publication Date
CL2016002890A1 true CL2016002890A1 (en) 2017-06-30

Family

ID=59858437

Family Applications (1)

Application Number Title Priority Date Filing Date
CL2016002890A CL2016002890A1 (en) 2016-11-14 2016-11-14 Peptides with antimicrobial activity

Country Status (2)

Country Link
CL (1) CL2016002890A1 (en)
WO (1) WO2018085954A1 (en)

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1133461C (en) * 2000-04-11 2004-01-07 厦门北大之路生物工程有限公司 Application of Huwen bird spider toxin extract in preparation of analgesic medicine
SG179101A1 (en) * 2009-09-15 2012-05-30 Alomone Preclinical Ltd Novel peptides isolated from spider venom, and uses thereof

Also Published As

Publication number Publication date
WO2018085954A1 (en) 2018-05-17

Similar Documents

Publication Publication Date Title
BR112017028413A2 (en) stabilized antimicrobial peptides
CL2018001349A1 (en) Compositions comprising bacterial strains
CL2018001367A1 (en) Compositions comprising bacterial strains
MX2015015506A (en) Antimicrobial peptide.
CL2017003142A1 (en) Compositions comprising bacterial strains
BR112016016274A2 (en) BLOOD-BRAIN BARRIER BRIDGE
PE20180243A1 (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS
CL2016002971A1 (en) Combination.
PE20180266A1 (en) COMPOSITIONS INCLUDING BACTERIAL STRAINS
MX369041B (en) CHEMERICAL PROTEINS TYPE ALKALINE PHOSPHATASE.
GT201600249A (en) NEW DERIVATIVES OF PIRAZOLO PIRIMIDINA AND ITS USE AS INHIBITORS OF MALT1
BR112017028318A2 (en) antibacterial compounds
CL2016000839A1 (en) Compositions to modulate the expression of c9orf72.
EA201400986A1 (en) PHARMACEUTICAL COMPOSITIONS CONTAINING METHORMEN AND DPP-4 INHIBITOR OR SGLT-2 INHIBITOR
MX2020012132A (en) AZAPIRIDONE COMPOUNDS AND USES THEREOF.
CR20160485A (en) CYCLOPROPANAMINE COMPOUND AND ITS USES
UY35276A (en) New compounds that inhibit the activity of Lp-PLA2
CU24580B1 (en) ATTENUATED VECTORS OF INFLUENZA FOR THE PREVENTION AND/OR TREATMENT OF INFECTIOUS DISEASES AND FOR THE TREATMENT OF ONCOLOGICAL DISEASES
MX2017011655A (en) AZA-PIRIDONA COMPOUNDS AND USES OF THESE.
CL2019002574A1 (en) Modulators of pcsk9 expression.
CL2018000228A1 (en) New effective aminoglycoside antibiotic for multi-drug resistant bacteria.
DOP2017000260A (en) VORTIOXETINE PYROGLUTAMATE
CL2016002879A1 (en) Pharmaceutical compositions for treating infectious diseases
CL2017002451A1 (en) Novel heterocyclic compounds and their use in the prevention or treatment of bacterial infections
DOP2018000049A (en) COMPOUNDS FOR USE IN ANTIBACTERIAL APPLICATIONS